A clinical study of transcranial alternating current stimulation for mood and sleep regulation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057847

Enrollment

Unknown

Registered

2022-03-19

Start date

2022-03-22

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosomatic disease

Interventions

Transcranial AC active stimulation insomnia group:Transcranial AC active stimulation

Transcranial AC sham stimulation insomnia group:Transcranial AC sham stimulation

Active stimulation anxiety group:Transcranial AC active stimulation

Sham stimulation-depression anxiety group:Transcranial AC sham stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years old, male or female; 2. Meet one of the following diagnoses in DSM-5: primary insomnia or depression and generalized anxiety disorder; 3. Moderate or severe; 4. Have not taken antidepressants or sleep aids in the past two weeks, or have taken drugs but the current symptoms are still obvious.

Exclusion criteria

Exclusion criteria: 1. Concomitant with other types of neuropsychiatric diseases; 2. History of traumatic brain injury or surgery; 3. Suicidal behavior, obvious suicidal ideation; 4. EEG or MRI contraindications; 5. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
Depression remission rate;Anxiety remission rate;insomnia response;	—

Secondary

Measure	Time frame
Improvement of somatization symptoms;Improvement of subjective cognition;	—

Countries

China

Contacts

Public ContactWang Kun

Beijing Puren Hospital

493107264@qq.com+86 13611362026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026